<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3APerpetual_subordinated_notes</id>
	<title>Definition:Perpetual subordinated notes - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3APerpetual_subordinated_notes"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Perpetual_subordinated_notes&amp;action=history"/>
	<updated>2026-06-15T18:55:26Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Perpetual_subordinated_notes&amp;diff=12242&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Perpetual_subordinated_notes&amp;diff=12242&amp;oldid=prev"/>
		<updated>2026-03-12T09:57:50Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📜 &amp;#039;&amp;#039;&amp;#039;Perpetual subordinated notes&amp;#039;&amp;#039;&amp;#039; are [[Definition:Debt instrument | debt instruments]] with no fixed maturity date that rank below senior creditors but above [[Definition:Shareholders&amp;#039; equity | equity holders]] in an insurer&amp;#039;s capital structure. Insurance groups issue these securities primarily to bolster their regulatory capital — under [[Definition:Solvency II | Solvency II]], perpetual subordinated debt can qualify as [[Definition:Tier 1 capital | Tier 1]] own funds (subject to conditions and limits), while equivalent recognition exists under other frameworks such as the [[Definition:Risk-based capital (RBC) | RBC]] regime in the United States and [[Definition:C-ROSS | C-ROSS]] in China. Their perpetual nature and subordination features give them equity-like loss-absorbing characteristics while still providing tax-deductible coupon payments, making them a hybrid financing tool that sits at the intersection of debt and equity.&lt;br /&gt;
&lt;br /&gt;
⚙️ Despite being labeled &amp;quot;perpetual,&amp;quot; these notes almost always include a call option that allows the issuer to redeem them after a specified period — typically five or ten years from issuance. Regulators generally require that the notes carry mandatory [[Definition:Coupon deferral | coupon deferral]] provisions triggered under defined stress scenarios, such as a breach of the [[Definition:Solvency capital requirement (SCR) | solvency capital requirement]] or a regulatory intervention event, and some structures include principal write-down or conversion-to-equity mechanisms. The coupon may be fixed initially, then reset to a floating rate at the first call date to create an economic incentive for redemption. Investors in these instruments — typically institutional fixed-income funds and insurance-specialist debt investors — price them based on the probability of call, the credit quality of the issuer, and the specific loss-absorption features embedded in the terms, resulting in yields that sit between senior unsecured debt and [[Definition:Common equity | common equity]] cost of capital.&lt;br /&gt;
&lt;br /&gt;
💡 For insurance groups, perpetual subordinated notes offer a way to optimize the capital structure without diluting existing shareholders. Issuing equity is expensive and dilutive; senior debt does not count toward regulatory capital. Perpetual subordinated notes occupy the efficient middle ground, strengthening [[Definition:Solvency ratio | solvency ratios]] at a cost of capital that, while higher than senior debt, remains well below the return demanded on equity. Large European insurers have been particularly active issuers, driven by the tiering rules under Solvency II that assign favorable capital treatment to instruments meeting specific subordination, permanence, and loss-absorption criteria. However, the complexity of these instruments — and the risk that coupons can be deferred or principal written down — means they require careful analysis by both issuers managing their [[Definition:Capital management | capital stack]] and investors assessing the risk-reward profile relative to other parts of the insurer&amp;#039;s liability structure.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Tier 1 capital]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Own funds]]&lt;br /&gt;
* [[Definition:Capital management]]&lt;br /&gt;
* [[Definition:Subordinated debt]]&lt;br /&gt;
* [[Definition:Hybrid capital]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>